Targeting PRMT5 alleviates diabetic cardiomyopathy: mechanisms involve Ndufs2 R118 dimethylation-mediated complex I protection and serum PRMT5 as a biomarker.
- DOI
- 10.1186/s10020-026-01594-2
- Published
- 2026 Aug 13
- Container
- Molecular medicine (Cambridge, Mass.)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s10020-026-01594-2,
title = {Targeting PRMT5 alleviates diabetic cardiomyopathy: mechanisms involve Ndufs2 R118 dimethylation-mediated complex I protection and serum PRMT5 as a biomarker.},
author = {Cai S and Su M and Li J and Yu Y and Wu M and Liu M and Wang R and Huang J and Lai Q and Chen C and Yiu KH},
year = {2026},
journal = {Molecular medicine (Cambridge, Mass.)},
doi = {10.1186/s10020-026-01594-2},
url = {https://doi.org/10.1186/s10020-026-01594-2}
}RIS
TY - JOUR TI - Targeting PRMT5 alleviates diabetic cardiomyopathy: mechanisms involve Ndufs2 R118 dimethylation-mediated complex I protection and serum PRMT5 as a biomarker. AU - Cai S AU - Su M AU - Li J AU - Yu Y AU - Wu M AU - Liu M AU - Wang R AU - Huang J AU - Lai Q AU - Chen C AU - Yiu KH PY - 2026 JO - Molecular medicine (Cambridge, Mass.) DO - 10.1186/s10020-026-01594-2 UR - https://doi.org/10.1186/s10020-026-01594-2 ER -
APA
S, C., M, S., J, L., Y, Y., M, W., M, L., R, W., J, H., Q, L., C, C., & KH, Y. (2026). Targeting PRMT5 alleviates diabetic cardiomyopathy: mechanisms involve Ndufs2 R118 dimethylation-mediated complex I protection and serum PRMT5 as a biomarker.. Molecular medicine (Cambridge, Mass.). https://doi.org/10.1186/s10020-026-01594-2
Source records
- pubmed · retrieved 2026-11-11T03:51:57.501Z